VMP 42107511000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Naproxen 250mg tablets
BNF code 1001010P0AAADAD
Virtual Therapeutic Moiety Naproxen
Date identifier became valid 28 Jul 2023
Previous product identifier 329806007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Naproxen
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Naprosyn 250mg tablets (Atnahs Pharma UK Ltd)
Naproxen 250mg tablets (A A H Pharmaceuticals Ltd)
Naproxen 250mg tablets (Accord-UK Ltd)
Naproxen 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Naproxen 250mg tablets (Almus Pharmaceuticals Ltd)
Naproxen 250mg tablets (Bristol Laboratories Ltd)
Naproxen 250mg tablets (Crescent Pharma Ltd)
Naproxen 250mg tablets (Genesis Pharmaceuticals Ltd)
Naproxen 250mg tablets (Medihealth (Northern) Ltd)
Naproxen 250mg tablets (Milpharm Ltd)
Naproxen 250mg tablets (Phoenix Healthcare Distribution Ltd)
Naproxen 250mg tablets (RX Farma)
Naproxen 250mg tablets (Sigma Pharmaceuticals Plc)
Naproxen 250mg tablets (Strides Pharma UK Ltd)
Naproxen 250mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Naproxen 250mg tablets 250 tablet
Naproxen 250mg tablets 28 tablet
Naproxen 250mg tablets 56 tablet
Naproxen 250mg tablets 84 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback